Clinical Trials Sponsored by Winnipeg Rh Institute Foundation Inc.

Total 294 results

University of Manitoba
Health Sciences Centre, Winnipeg, Manitoba; University of Utah; St. Boniface... and other collaborators

Unknown

Budesonide With Intratracheal Surfactants in Extremely Preterm Infants (BITS)

Bronchopulmonary Dysplasia | Respiratory Distress Syndrome in Premature Infant

Canada
Rebiscan, Inc.
Kaiser Foundation Research Institute

Completed

Improving Quality Vision Outcomes in Managed Care Setting While Reducing Cost by Use of Accurate, Automated Screening

Strabismus | Amblyopia

United States
NSABP Foundation Inc
Genentech, Inc.; International Drug Development Institute

Completed

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

Breast Cancer

United States, Canada
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery

Colorectal Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Terminated

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Colorectal Cancer | Precancerous Condition

United States, Canada
NSABP Foundation Inc
National Cancer Institute (NCI)

Active, not recruiting

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Breast Cancer

United States, Puerto Rico
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer

Breast Cancer

United States, Canada
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer

Breast Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Unknown

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Breast Cancer

United States, Canada, Puerto Rico
NSABP Foundation Inc
National Cancer Institute (NCI)

Unknown

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Breast Cancer
National Cancer Institute (NCI)
NSABP Foundation Inc

Completed

Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Liver Metastases | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Adenocarcinoma of the Rectum | Adenocarcinoma of the Colon

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery

Colorectal Cancer
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Breast Cancer

United States, Canada
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

Breast Cancer

United States, Canada, Puerto Rico
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

Breast Cancer

United States, Canada
National Cancer Institute (NCI)
NSABP Foundation Inc

Completed

Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer

Colon Adenocarcinoma | Stage IIIA Colon Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage IIIC Colon Cancer AJCC v7 | Stage IIA Colon Cancer AJCC v7 | Stage IIB Colon Cancer AJCC v7 | Stage IIC Colon Cancer AJCC v7

United States
Minneapolis Heart Institute Foundation
Osprey Medical, Inc

Terminated

REduction of Contrast Via DyeVert Used in CTO Procedures (REDUCe)

Chronic Total Occlusion of Coronary Artery

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer

Breast Cancer

Canada, United States, Puerto Rico
NSABP Foundation Inc
National Cancer Institute (NCI)

Terminated

Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Withdrawn

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

Breast Cancer | Fatigue
NSABP Foundation Inc
National Cancer Institute (NCI)

Terminated

Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer

Colorectal Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

Breast Cancer

United States, Canada
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Cancer

Breast Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Unknown

Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32

Depression | Breast Cancer | Fatigue | Sleep Disorders

United States, Canada
NSABP Foundation Inc
National Cancer Institute (NCI)

Unknown

Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial

Breast Cancer
NSABP Foundation Inc
National Cancer Institute (NCI)

Unknown

Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28

Breast Cancer
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Breast Cancer

United States, Canada
NSABP Foundation Inc
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

Colorectal Cancer | Metastatic Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer

Breast Cancer

United States, Canada, Puerto Rico
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen

Breast Cancer

United States, Canada, Puerto Rico
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Resected Colon Cancer

Colorectal Cancer
NSABP Foundation Inc
National Cancer Institute (NCI); Novartis

Active, not recruiting

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Breast Cancer

United States, Canada, Ireland
Friends Research Institute, Inc.
Conrad N. Hilton Foundation

Completed

Examining the Effectiveness of the FaCES Adolescent SBIRT Intervention

Adolescent Behavior | Adolescent Health Services

United States
NSABP Foundation Inc
Hoffmann-La Roche; Genentech, Inc.; International Drug Development Institute

Completed

Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer

Breast Cancer

United States
NSABP Foundation Inc
Hoffmann-La Roche; Genentech, Inc.; International Drug Development Institute

Terminated

Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon

Colorectal Neoplasms

United States
Mitralign, Inc.
CardioVascular Research Foundation, Korea; Regulatory and Clinical Research... and other collaborators

Unknown

Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) (SCOUT-II)

Heart Valve Disease | Tricuspid Valve Insufficiency | Chronic Symptomatic Functional Tricuspid Regurgitation

Italy, Netherlands, Germany, Portugal
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); NSABP Foundation Inc

Completed

Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer

Breast Cancer | Perioperative/Postoperative Complications

United States, Canada
Laureate Institute for Brain Research, Inc.
Brain & Behavior Research Foundation

Active, not recruiting

Augmented Interoceptive Exposure Training in Anorexia Nervosa

Anorexia Nervosa

United States
MapHabit, Inc.
National Institute on Aging (NIA); LuMind IDSC Foundation

Completed

Life Skills Improved in Children With Down Syndrome After Using Assistive Technology

Quality of Life | Down Syndrome | Adaptive Behavior

United States
Regenstrief Institute, Inc.
Merck Sharp & Dohme LLC; National Sleep Foundation

Unknown

Testing Utility of Commercially Available Sleep Trackers for Physician-Patient Communication

Insomnia

United States
TriHealth Inc.
TriHealth Hatton Research Institute; Bethesda North Hospital Foundation

Terminated

Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT) (TARGIT)

Early Stage Breast Cancer | Breast Tumor | Neoplasm of the Breast

United States
Johns Hopkins University
National Institute on Aging (NIA); Retirement Research Foundation; Abell Foundation and other collaborators

Completed

The Baltimore Experience Corps Study

Aging | Generativity

United States
Laureate Institute for Brain Research, Inc.
Brain & Behavior Research Foundation

Completed

Frontoparietal Synchronization to Modulate Drug Craving in Opioid Use Disorder (FPS_Opioid)

Opioid-use Disorder

United States
Lawson Health Research Institute
Smith & Nephew, Inc.; Canadian Orthopaedic Foundation

Completed

Assessment of Conventional and Patient-specific Instrumentation in Total Knee Arthroplasty

Osteoarthritis

Canada
Pear Therapeutics, Inc.
National Institute on Drug Abuse (NIDA); Kaiser Foundation Research Institute; Whitman-Walker Institute, Inc... and other collaborators

Completed

Feasibility Study of Novel Prescription Digital Therapeutic Supporting Unobserved Buprenorphine Initiation & Adherence

Opioid Use Disorder

United States
NSABP Foundation Inc
Royal Marsden NHS Foundation Trust; Pfizer; Institute of Cancer Research, United...

Completed

A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer (PALLET)

Breast Cancer | Breast Tumors | Breast Carcinoma

United Kingdom, United States, Canada
Ponce Medical School Foundation, Inc.
National Institute of Mental Health (NIMH)

Recruiting

Intervention to Reduce Serious Mental Illness and Suicide Stigma Among Medical Students

Stigmatization | Clinical Competence

United States, Puerto Rico
Klein Buendel, Inc.
University of Colorado, Denver; Kaiser Foundation Research Institute

Completed

Sun Safe Workplaces: A Campaign on Sun Protection Policies for Outdoor Workers (SSW)

Skin Cancer

United States
Yale University
National Institute on Drug Abuse (NIDA); APT Foundation, Inc.

Completed

Automated Recovery Line for Medication Assisted Treatment

Substance Use Disorders | Drug Dependence

United States
Public Health Foundation Enterprises, Inc.
National Institute of Mental Health (NIMH)

Completed

Examining Hair to Determine Tenofovir Exposure

HIV

United States

Clinical Trials Sponsored by Winnipeg Rh Institute Foundation Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations